With cannabis use becoming widespread, new challenges such as understanding and avoiding possible negative interactions with pharmaceutical drugs are important issues.
Bluebird Bio Inc (NASDAQ: BLUE) shares are trading lower Monday. The stock initially surged in premarket trading following the U.S. Food and Drug Administration's accelerated approval of SKYSONA, but it turned sharply lower at the open.
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates for the week of Sept. 19, according to Fintel Data:
Sharecare Inc (NASDAQ: SHCR) shares are trading higher by 8.08% to $1.80 Monday morning after the company received three-year Wellness and Health Promotion Accreditation by the National Committee for Quality Assurance for its lifestyle and disease management interventions.
Allakos Inc (NASDAQ: ALLK) shares are trading higher by 29.26% to $5.92 during Monday's trading session after the company priced an underwritten offering of roughly 29.88 million shares of common stock at $5.02 per share.
Susquehanna cut the price target on NetApp, Inc. (NASDAQ: NTAP) from $100 to $75. Susquehanna analyst Mehdi Hosseini also downgraded the stock from Positive to Neutral. NetApp shares fell 1.3% to trade at $67.76 on Monday.